Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma.
about
Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.Bioinformatics-Based Identification of MicroRNA-Regulated and Rheumatoid Arthritis-Associated GenesGenetically modified T-cell therapy for osteosarcomaA Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric ImmunoreceptorsMicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer.Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.Genetically Modified T-cell Therapy for the Treatment of Osteosarcoma: An Update.Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts.High expression of MACC1 predicts poor prognosis in patients with osteosarcoma.Fibroblast activation protein in osteosarcoma cells promotes angiogenesis via AKT and ERK signaling pathways.
P2860
Q34075875-6759A115-F69D-42A5-939C-12AC640846D9Q35182174-69DB7F3C-EC6D-4DC2-B035-64FDE345AD8DQ35770347-2DA7E436-959E-414E-B438-99764F395822Q36198232-443B1B4D-1B17-4733-8891-698E075691B0Q36617953-6AD68E51-F26E-4944-9455-D4B1D1DBBC19Q37410661-1931B4F1-C817-490D-AD52-EF9BBA3C652EQ37413637-5885AFF9-823E-4510-821D-5165F328D278Q38426341-709058CE-86F3-42A7-8446-5148D1327F44Q38889691-A175F3EF-96BF-4F4C-94CC-D076AFD89969Q39041457-4F7D80DB-D4F1-45B1-81B2-7E3F04F7C714Q39377477-AC139537-EBE1-4F3B-83B5-C1402389B33FQ42576424-A07494E8-D372-46EF-8C32-522969E3B5CEQ42634367-21C27C2E-7325-4A5D-AEFC-A9012BE642B5Q47285215-52E4400A-9ACB-41DD-BB88-18D9139EA360Q53248873-52B7E4E0-741D-47FC-8151-4FCD086EF55FQ54982013-5F55ABAC-DCC7-44B5-8C9E-58BC96BCBF09
P2860
Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Overexpression of fibroblast a ...... in patients with osteosarcoma.
@en
Overexpression of fibroblast a ...... in patients with osteosarcoma.
@nl
type
label
Overexpression of fibroblast a ...... in patients with osteosarcoma.
@en
Overexpression of fibroblast a ...... in patients with osteosarcoma.
@nl
prefLabel
Overexpression of fibroblast a ...... in patients with osteosarcoma.
@en
Overexpression of fibroblast a ...... in patients with osteosarcoma.
@nl
P2093
P2860
P356
P1476
Overexpression of fibroblast a ...... in patients with osteosarcoma.
@en
P2093
Beibei Liu
Dongtang Yuan
Guotai Zhu
Kaixiang Liu
Zhitang Dai
P2860
P304
P356
10.1002/JSO.23368
P577
2013-06-28T00:00:00Z